Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Cell Signal. 2012 Mar;24(3):596-605. doi: 10.1016/j.cellsig.2011.11.008. Epub 2011 Nov 13.
Peroxisome proliferator-activated receptor-γ (PPARγ) is a nuclear receptor with transcriptional activity controlling multiple physical and pathological processes. Recently, PPARγ has been implicated in the pathogenesis of liver fibrosis. Its depleted expression has strong associations with the activation and transdifferentiation of hepatic stellate cells, the central event in liver fibrogenesis. Studies over the past decade demonstrate that PPARγ cross-regulates a number of signaling pathways mediated by growth factors and adipokines, and cellular events including apoptosis and senescence. These signaling and cellular events and their molecular interactions with PPARγ system are profoundly involved in liver fibrogenesis. We critically summarize these mechanistic insights into the PPARγ regulation in liver fibrogenesis based on the updated findings in this area. We conclude with a discussion of the impacts of these discoveries on the interpretation of liver fibrogenesis and their potential therapeutic implications. PPARγ activation could be a promising strategy for antifibrotic therapy.
过氧化物酶体增殖物激活受体-γ(PPARγ)是一种具有转录活性的核受体,可控制多种生理和病理过程。最近,PPARγ 被牵连到肝纤维化的发病机制中。其耗竭表达与肝星状细胞的激活和转分化密切相关,肝纤维化的中心事件。过去十年的研究表明,PPARγ 交叉调节由生长因子和脂肪因子介导的许多信号通路,以及包括细胞凋亡和衰老在内的细胞事件。这些信号和细胞事件及其与 PPARγ 系统的分子相互作用,都与肝纤维化的发生密切相关。我们根据该领域的最新发现,批判性地总结了这些关于 PPARγ 调控肝纤维化的机制见解。最后,我们讨论了这些发现对肝纤维化解释的影响及其潜在的治疗意义。PPARγ 激活可能是抗纤维化治疗的一种有前途的策略。